About the BRCC

How the BRCC Operates

The BRCC supports promising new life sciences ventures entering the commercialization phases of development in a number of ways:

Startup and Gap Funding Assistance

BioLaunch Pharmaceutical Development Services

Core Technology Alliance

 

Startup and Gap Funding Assistance

Promising new ventures or individuals can apply to the BRCC for startup and Gap Funding assistance.

Access our Investment Strategy, Investment Criteria, and Investment Process

 

BioLaunch Pharmaceutical Development Services

As the founding place of The Upjohn Company and The Stryker Corporation, Kalamazoo, Michigan has a heritage of more than a century of drug development and medical device experience. This life sciences heritage has continued as an entrepreneurial business climate, scientific talent and funding sources have spawned a new generation of life science startup companies.

BioLaunch describes a BRCC function (e.g., we help launch new pharmaceutical, device and diagnostic companies). BioLaunch is staffed with industry trained pharmaceutical scientists and commercialization experts and also utilizes regional talent to provide these services for corporate clients, startup companies, and University Technology Transfer Offices.

BioLaunch can assist their clients in all aspects of pharmaceutical development, and fees are negotiable with services provided in exchange for cash, equity, royalties or a combination of these.

 

Core Technology Alliance

The BRCC is a member of the Core Technology Alliance (see www.ctaalliance.org). The mission of the Core Technology Alliance is to develop a collaborative network of technologically sophisticated core facilities to enhance life sciences research and product development throughout the State of Michigan. The BRCC brings a pharmaceutical commercialization expertise to the alliance.